Allurion surges on weight loss data from gastric balloon, GLP-1 combo treatment
Allurion Technologies' gastric balloon and Novo Nordisk's semaglutide achieved 20.3% weight loss in a trial. Read more here.
Allurion Technologies balloon data ‘intriguing,’ says Chardan
Chardan notes that Allurion has announced additional data evaluating the use of its Allurion Balloon in combination with patients be treated ...
Allurion Technologies’ gastric balloon+GLP1s may become new SOC, says Roth MKM
Roth MKM keeps a Buy rating and $16 price target on Allurion Technologies (ALUR) after its initial results from Allurion Program-GLP-1 combo.
Allurion Technologies (ALUR) Projected to Post Quarterly Earnings on Wednesday
Allurion Technologies (NYSE:ALUR – Get Free Report) is anticipated to release its earnings data before the market opens on ...
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced initial results on the combination of the Allurion Program with low-dose ...
Best Small Cap Stocks To Consider – March 22nd
Forman, and Allurion Technologies are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small cap stocks represent shares of smaller companies, typically with ...
Investing4d
Allurion reports weight loss and muscle gain with new therapy
The Allurion Program includes a swallowable gastric balloon, which is part of a broader weight-loss platform that also features virtual care and a behavior change program. With revenue of $34.75 ...
Yahoo Finance20d
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity
These patents, both of which are scheduled to issue on March 11, 2025, provide additional claims for an enhanced, next-generation version of Allurion’s proprietary Balloon technology for the ...
Allurion Shares Surge 40% on Positive Results from Weight-Loss Study
Shares of Allurion Technologies on Friday surged a day after the company said it received positive results about the effectiveness of its gastric balloon in combination with a low dose of the ...